You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Intratumoral gemcitabine levels

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Squamous Cell Carcinoma of the Head and Neck, Paclitaxel, Carboplatin Trial in Amiens (GCP intratumoral catheter)

Not yet recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • +3 more
  • intratumoral catheter
  • Amiens, Picardie, France
    CHU Amiens Picardie
Apr 26, 2023

Pancreatic Adenocarcinoma Trial in France (Gene Therapy product CYL-02, Gemcitabine)

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • Clichy, France
  • +6 more
Oct 27, 2021

Pancreatic Cancer Trial in Houston (genetic, drug, biological)

Recruiting
  • Pancreatic Cancer
  • delolimogene mupadenorepvec
  • +3 more
  • Houston, Texas
  • +1 more
Sep 16, 2022

Metastatic Pancreatic Cancer Trial in Scottsdale (diagnostic test, other, drug)

Completed
  • Metastatic Pancreatic Cancer
  • Safety Laboratories
  • +7 more
  • Scottsdale, Arizona
    HonorHealth Research Institute
Jul 14, 2021

Advanced Solid Tumor Trial in Canada, United States (SRF617, Gemcitabine, Albumin-Bound Paclitaxel)

Active, not recruiting
  • Advanced Solid Tumor
  • Duarte, California
  • +9 more
Nov 28, 2022

Advanced Solid Tumor Trial in Boston (VAX014)

Not yet recruiting
  • Advanced Solid Tumor
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jun 2, 2023

Pancreatic Cancer, Unresectable Pancreatic Cancer, Pancreatic Adenocarcinoma Trial (DaRT seeds insertion)

Not yet recruiting
  • Pancreatic Cancer
  • +2 more
  • DaRT seeds insertion
  • (no location specified)
Sep 5, 2023

Pancreatic Cancer Trial in Houston (Gemcitabine)

Terminated
Has Results
  • Pancreatic Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 15, 2020

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Scottsdale (Paricalcitol (Zemplar))

Active, not recruiting
  • Pancreatic Cancer
  • +4 more
  • Paricalcitol (Zemplar)
  • Scottsdale, Arizona
    HonorHealth Research Institute
Feb 16, 2022

Metastatic Pancreatic Cancer Trial in France, Martinique (Irinotecan Liposomal Injection, 5-FU/LV, Nab-Paclitaxel)

Recruiting
  • Metastatic Pancreatic Cancer
  • Irinotecan Liposomal Injection
  • +3 more
  • Amiens, France
  • +35 more
Mar 23, 2022

Pancreatic Cancer, Unresectable Pancreatic Cancer, Metastatic Pancreatic Cancer Trial (Radiation: Diffusing Alpha Radiation

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
  • (no location specified)
Dec 11, 2022

Basal Cell Carcinoma Trial in Ljubljana (phIL12 GET)

Recruiting
  • Basal Cell Carcinoma
  • phIL12 GET
  • Ljubljana, Slovenia
  • +1 more
Nov 8, 2022

Bladder Urothelial Carcinoma In Situ, Infiltrating Bladder Mixed Carcinoma, Stage 0a Bladder Cancer AJCC v8 Trial in Guam,

Recruiting
  • Bladder Urothelial Carcinoma In Situ
  • +4 more
  • Gemcitabine Hydrochloride
  • Pembrolizumab
  • Birmingham, Alabama
  • +379 more
Aug 23, 2022

Pancreatic Adenocarcinoma, Ovarian Cancer, Biliary Carcinoma Trial in Stockholm, Uppsala (LOAd703)

Recruiting
  • Pancreatic Adenocarcinoma
  • +3 more
  • Stockholm, Sweden
  • +1 more
Apr 4, 2022

Pancreatic Cancer Metastatic Trial (C3 (Metformin, Simvastatin, and Digoxin))

Not yet recruiting
  • Pancreatic Cancer Metastatic
  • C3 (Metformin, Simvastatin, and Digoxin)
  • (no location specified)
Sep 1, 2023

Prostate Adenocarcinoma Trial in Haifa (Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT))

Recruiting
  • Prostate Adenocarcinoma
  • Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
  • Haifa, Israel
  • +1 more
Jul 4, 2022

Metastatic Lung Cancer, Metastatic Breast Cancer, Metastatic Gastric Cancer Trial in Rotterdam (Tusamitamab ravtansine)

Not yet recruiting
  • Metastatic Lung Cancer
  • +2 more
  • Tusamitamab ravtansine
  • Rotterdam, Netherlands
    Erasmus MC
Jan 26, 2023

Non Small Cell Lung Cancer, Solid Tumor Trial in Jette, Brussel (Avelumab, Ipilimumab 5 MG/ML, Pembrolizumab 100 MG in 4 ML

Recruiting
  • Non Small Cell Lung Cancer
  • Solid Tumor
  • Jette, Brussels, Belgium
  • +1 more
Sep 9, 2022

Solid Tumor Trial (BS006 Injection)

Not yet recruiting
  • Solid Tumor
  • BS006 Injection
  • (no location specified)
Jul 3, 2023

Urothelial Carcinoma Bladder, Androgen Receptor Positive Trial in Providence (Degarelix, Gemcitabine/Cisplatin)

Not yet recruiting
  • Urothelial Carcinoma Bladder
  • Androgen Receptor Positive
  • Providence, Rhode Island
    Lifespan Cancer Institute
May 1, 2023

Advanced Solid Tumor, Lung Cancer, Pancreas Cancer Trial in Chengdu (CNSI-Fe(II) 30 mg, CNSI-Fe(II) 60 mg, CNSI-Fe(II) 90 mg)

Recruiting
  • Advanced Solid Tumor
  • +8 more
  • CNSI-Fe(II) 30 mg
  • +2 more
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Sep 15, 2023

Low-grade Glioma, IDH2 Gene Mutation, Recurrent Glioma Trial in Boston (Niraparib, Resection/Treatment with Niraparib)

Recruiting
  • Low-grade Glioma
  • +4 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 19, 2022

Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma Trial in Bethesda, Boston (Biopsy,

Recruiting
  • Advanced Fallopian Tube Carcinoma
  • +21 more
  • Biopsy
  • +2 more
  • Bethesda, Maryland
  • +2 more
Jan 25, 2023

Pancreatic Cancer Trial in Boston, Philadelphia (Gemcitabine, Nab-paclitaxel, Paricalcitol)

Active, not recruiting
  • Pancreatic Cancer
  • Boston, Massachusetts
  • +1 more
Jan 9, 2023

Recurrent NSCLC, Stage IV NSCLC Trial in Detroit (docetaxel, pemetrexed disodium, gemcitabine HCl)

Terminated
Has Results
  • Recurrent Non-small Cell Lung Cancer
  • Stage IV Non-small Cell Lung Cancer
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Sep 3, 2020